Ingredient intelligence

Ferulic acid

Antioxidant · Ferulic Acid · C10H10O4

Ferulic acid is a plant phenolic acid studied both as an antioxidant and as a stabiliser in vitamin C and E formulations.

Molecular identity

Two-dimensional chemical structure of Ferulic acid
Formula
C10H10O4
Molecular weight
194.18 g/mol
PubChem CID
445858
ChEBI
CHEBI:17620
Open PubChem record →

Biological targets

  • NF-E2-related factor 2 (NFE2L2)

    low confidence

    activates · receptor

    UniProt Q16236
  • Reactive oxygen species

    medium confidence

    inhibits · complex

    Direct chemical scavenging.

Molecules & genes

Molecules

  • Ferulic acidC10H10O4 · 194.18 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
Ferulic acidFerulic acidReactive oxygen speciesDetoxification of reactiv…Oxidative stress response

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

5 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Ferulic acid is molecule Ferulic acidhigh confidence
  • Ferulic acid inhibits Reactive oxygen speciesmedium confidence
  • Detoxification of reactive oxygen species associated with Oxidative stress responsemedium confidence

Biological pathways

KEAP1-NFE2L2 antioxidant response

low confidence

Antioxidant response element activation reported in cell models.

Reactome R-HSA-9755511

Detoxification of reactive oxygen species

medium confidence

Radical scavenging capacity.

Reactome R-HSA-3299685

Evidence engine

Limited

Mostly mechanistic, animal or single-study evidence.

Skinceptor Evidence Index

40

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • Human1
  • In-vitro1
Total studies
2
Human studies
1
Largest sample
9
Range
2005–2013

Index breakdown

  • Study design quality48% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share33% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume50% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size32% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication33% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency35% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability50% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 2005

    Ferulic acid stabilises a solution of vitamins C and E and doubles its photoprotection

    Humann = 9 · Journal of Investigative Dermatology

  2. 2013

    Stability of L-ascorbic acid in topical formulations

    In-vitrosample size unavailable · International Journal of Cosmetic Science

Ingredient fingerprint

10 nodes · 12 relationships · seed "ferulic-acid"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

2 curated studies

In-vitroInternational Journal of Cosmetic Science · 2013

Stability of L-ascorbic acid in topical formulations

Reported rapid oxidative degradation of L-ascorbic acid at neutral pH, mitigated by low pH and antioxidant co-formulation.

LimitationsFormulation chemistry only; no biological endpoints.

Identifier not curated — search Europe PMCL-Ascorbic acid · Ferulic acid · Tocopherol
HumanJournal of Investigative Dermatology · 2005n = 9

Ferulic acid stabilises a solution of vitamins C and E and doubles its photoprotection

Reported improved formulation stability and increased measured photoprotection for a C/E/ferulic combination on human skin.

LimitationsVery small sample; surrogate photoprotection endpoints; industry-affiliated.

PMID 16297196Ferulic acid · L-Ascorbic acid · Tocopherol

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources